95 related articles for article (PubMed ID: 15252116)
1. cAMP-induced degradation of cyclin D3 through association with GSK-3beta.
Naderi S; Gutzkow KB; Låhne HU; Lefdal S; Ryves WJ; Harwood AJ; Blomhoff HK
J Cell Sci; 2004 Aug; 117(Pt 17):3769-83. PubMed ID: 15252116
[TBL] [Abstract][Full Text] [Related]
2. Degradation of cyclin D3 independent of Thr-283 phosphorylation.
Låhne HU; Kloster MM; Lefdal S; Blomhoff HK; Naderi S
Oncogene; 2006 Apr; 25(17):2468-76. PubMed ID: 16331257
[TBL] [Abstract][Full Text] [Related]
3. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
[TBL] [Abstract][Full Text] [Related]
4. Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia.
Umar S; Wang Y; Morris AP; Sellin JH
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G599-607. PubMed ID: 17053159
[TBL] [Abstract][Full Text] [Related]
5. P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation.
Casanovas O; Jaumot M; Paules AB; Agell N; Bachs O
Oncogene; 2004 Sep; 23(45):7537-44. PubMed ID: 15326477
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
Diehl JA; Cheng M; Roussel MF; Sherr CJ
Genes Dev; 1998 Nov; 12(22):3499-511. PubMed ID: 9832503
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
8. pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation.
De Santa F; Albini S; Mezzaroma E; Baron L; Felsani A; Caruso M
Mol Cell Biol; 2007 Oct; 27(20):7248-65. PubMed ID: 17709384
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3beta phosphorylates p21WAF1/CIP1 for proteasomal degradation after UV irradiation.
Lee JY; Yu SJ; Park YG; Kim J; Sohn J
Mol Cell Biol; 2007 Apr; 27(8):3187-98. PubMed ID: 17283049
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.
Li M; Wang X; Meintzer MK; Laessig T; Birnbaum MJ; Heidenreich KA
Mol Cell Biol; 2000 Dec; 20(24):9356-63. PubMed ID: 11094086
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells.
Kida A; Kakihana K; Kotani S; Kurosu T; Miura O
Oncogene; 2007 Oct; 26(46):6630-40. PubMed ID: 17486076
[TBL] [Abstract][Full Text] [Related]
13. GSK-3beta reduces cAMP-induced cholecystokinin gene expression by inhibiting CREB binding.
Hansen Tv; Rehfeld JF; Nielsen FC
Neuroreport; 2004 Apr; 15(5):841-5. PubMed ID: 15073527
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP inhibits translation of cyclin D3 in T lymphocytes at the level of elongation by inducing eEF2-phosphorylation.
Gutzkow KB; Låhne HU; Naderi S; Torgersen KM; Skålhegg B; Koketsu M; Uehara Y; Blomhoff HK
Cell Signal; 2003 Sep; 15(9):871-81. PubMed ID: 12834812
[TBL] [Abstract][Full Text] [Related]
15. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms.
Liu R; Wang L; Chen C; Liu Y; Zhou P; Wang Y; Wang X; Turnbull J; Minassian BA; Liu Y; Zheng P
Mol Cell Biol; 2008 Dec; 28(23):7236-44. PubMed ID: 18824542
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.
Zhang F; Phiel CJ; Spece L; Gurvich N; Klein PS
J Biol Chem; 2003 Aug; 278(35):33067-77. PubMed ID: 12796505
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons.
Trivedi N; Marsh P; Goold RG; Wood-Kaczmar A; Gordon-Weeks PR
J Cell Sci; 2005 Mar; 118(Pt 5):993-1005. PubMed ID: 15731007
[TBL] [Abstract][Full Text] [Related]
18. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
Cao Q; Feng YJ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
[TBL] [Abstract][Full Text] [Related]
19. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner.
Caspi M; Zilberberg A; Eldar-Finkelman H; Rosin-Arbesfeld R
Oncogene; 2008 Jun; 27(25):3546-55. PubMed ID: 18223684
[TBL] [Abstract][Full Text] [Related]
20. Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate.
Twomey C; McCarthy JV
FEBS Lett; 2006 Jul; 580(17):4015-20. PubMed ID: 16814287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
